Zimmer Biomet Holdings (ZBH) Net Income (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Net Income came in at $238.3 million in Q1 2026, up 30.58% year-on-year from $182.5 million in Q1 2025, and up 129.05% quarter-over-quarter from -$820.4 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Net Income (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Net Income history runs 18 years deep, the most recent figure standing at $238.3 million for Q1 2026.
- On a quarterly basis, Net Income rose 30.58% year-over-year to $238.3 million in Q1 2026; TTM through Mar 2026 was -$197.5 million, a 251.81% decrease from a year earlier, with the FY2025 full-year figure at -$253.2 million, changed N/A from the prior year.
- Net Income rose to $238.3 million in Q1 2026 per ZBH's latest filing, from -$820.4 million in the prior quarter.
- Across five years, Net Income topped out at $419.7 million in Q4 2023 and bottomed at -$820.4 million in Q4 2025.
- The 5-year median for Net Income is $196.2 million (2023), against an average of $76.6 million.
- Across the five-year window, Net Income slumped 1351.06% in 2022 and jumped 495.75% in 2023, its largest moves.
- Year by year, Net Income stood at -$58.8 million in 2022, then surged by 813.78% to $419.7 million in 2023, then plunged by 229.78% to -$544.7 million in 2024, then slumped by 50.62% to -$820.4 million in 2025, then surged by 129.05% to $238.3 million in 2026.
- Per Business Quant, the three latest ZBH Net Income figures stand at $238.3 million (Q1 2026), -$820.4 million (Q4 2025), and $231.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | 238.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 238.30 Mn |
| Dec 31, 2025 | -820.40 Mn |
| Sep 30, 2025 | 231.20 Mn |
| Jun 30, 2025 | 153.40 Mn |
| Mar 31, 2025 | 182.50 Mn |
| Dec 31, 2024 | -544.70 Mn |
| Sep 30, 2024 | 249.20 Mn |
| Jun 30, 2024 | 243.10 Mn |
| Mar 31, 2024 | 172.80 Mn |
| Dec 31, 2023 | 419.70 Mn |
| Sep 30, 2023 | 162.80 Mn |
| Jun 30, 2023 | 209.90 Mn |
| Mar 31, 2023 | 232.70 Mn |
| Mar 31, 2022 | -58.80 Mn |
| Dec 31, 2021 | -29.20 Mn |
| Sep 30, 2021 | -16.60 Mn |
| Jun 30, 2021 | -2.30 Mn |
| Mar 31, 2021 | 4.70 Mn |
| Dec 31, 2020 | 401.30 Mn |
| Sep 30, 2020 | 246.10 Mn |